Oncotype Dx Score, HER2 Low Expression, and Clinical Outcomes in Early-Stage Breast Cancer: A National Cancer Database Analysis.

Arya Mariam Roy,Changchuan Jiang,Stuthi Perimbeti,Lei Deng,Charles L Shapiro,Shipra Gandhi

Cancers（2023）

引用 0|浏览19

暂无评分

摘要

Resectable HER2-low BC had a better prognosis than HER2-zero BC. Among those who received adjuvant chemotherapy in the higher oncotype RS group, those with HER2-low tumors had better survival.

查看译文

关键词

her2 low expression,breast cancer,early-stage

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要